Z.M.D. Medical
Immune-based Cancer Treatment
Health Tech & Life Sciences
Non Active, Sep 2021 ceased to operate
Company Overview
Snapshot
Founded in August 2014 by Barak Zigdon and Mark Gaides, Z.M.D. Medical operates with 1–10 employees. The company has raised $659.03K across two funding rounds from one investor. In May 2018, Z.M.D.
Business overview
Z.M.D. Medical is a Health Tech & Life Sciences company focused on developing immune-based cancer treatments. The company's core product, ONCARIN, is a probiotic preparation designed to rehabilitate distressed colon microflora, enabling the immune system to eliminate cancer. Operating within the Pharmaceuticals sector, Z.M.D. Medical aims to prevent and reverse cancerous conditions by restoring immune system function.
Company Intelligence Q&A
- What is Z.M.D. Medical's primary focus?
- Z.M.D. Medical develops and commercializes therapeutic remedies for cancer treatment by leveraging the patient's immune system.
- When was Z.M.D. Medical founded?
- Z.M.D. Medical was founded in August 2014.
- Who are the founders of Z.M.D. Medical?
- Barak Zigdon and Mark Gaides are the co-founders of Z.M.D. Medical.
- What is ONCARIN?
- ONCARIN is Z.M.D. Medical's probiotic product, consisting of a blend of five lyophilized bacteria species, designed to rehabilitate colon microflora and enhance the immune system's ability to combat cancer.